Amgen Inc.
AMGN
$296.47
$6.182.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.41% | -9.67% | |||
| Total Other Revenue | 47.83% | -25.41% | |||
| Total Revenue | 12.64% | -10.31% | |||
| Cost of Revenue | 2.57% | 265.87% | |||
| Gross Profit | 17.37% | -33.80% | |||
| SG&A Expenses | 0.24% | -10.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 156.67% | -53.85% | |||
| Total Operating Expenses | 6.47% | 32.63% | |||
| Operating Income | 27.94% | -50.27% | |||
| Income Before Tax | -20.53% | 152.30% | |||
| Income Tax Expenses | -44.03% | 56.77% | |||
| Earnings from Continuing Operations | -17.23% | 175.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.23% | 175.92% | |||
| EBIT | 27.94% | -50.27% | |||
| EBITDA | 16.31% | -37.79% | |||
| EPS Basic | -17.23% | 175.40% | |||
| Normalized Basic EPS | -19.70% | -61.32% | |||
| EPS Diluted | -17.19% | 176.36% | |||
| Normalized Diluted EPS | -19.70% | -61.17% | |||
| Average Basic Shares Outstanding | 0.00% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.18% | |||
| Dividend Per Share | 0.00% | 5.78% | |||
| Payout Ratio | 0.21% | -0.62% | |||